Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
Public ClinicalTrials.gov record NCT01281917. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of Velcade and Temsirolimus for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The investigators want to find out if the drugs Velcade and temsirolimus given together are effective in treating cancer. Velcade and temsirolimus are each FDA approved individually for certain types of cancer (Velcade for multiple myeloma and mantle cell lymphoma, and temsirolimus for renal cell carcinoma) but are not currently approved in combination for B-cell non-Hodgkin lymphoma. The investigators are trying to find out if giving these 2 drugs together will improve the period of time that the patient's cancer is stopped or slowed from growing and causing symptoms.
Study identification
- NCT ID
- NCT01281917
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2011 (Type not available)
- Primary completion
- Oct 2013 (Actual)
- Completion
- Jun 2014 (Actual)
- Last update posted
- Dec 13, 2019
2011 – 2014
United States locations
- U.S. sites
- 18
- U.S. states
- 2
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rapid City Regional Hospital John T. Vucurevich Cancer Care Institute | Rapid City | South Dakota | 57701 | — |
| Aurora Baycare Medical Center-GreenBay | Green Bay | Wisconsin | 54143 | — |
| St Vincent Regional Cancer Center CCOP | Green Bay | Wisconsin | 54301 | — |
| Bellin Memorial Hospital, Inc | Green Bay | Wisconsin | 54313 | — |
| Gunderson Lutheran Health System | La Crosse | Wisconsin | 54601 | — |
| UW Health Oncology- 1 S Park | Madison | Wisconsin | 53715 | — |
| University Of Wisconsin Cancer Center | Madison | Wisconsin | 53792 | — |
| Aurora BayCare Medical Center | Marinette | Wisconsin | — | — |
| Marshfield Clinic | Marshfield | Wisconsin | 54449 | — |
| Columbia St Mary's, Inc | Milwaukee | Wisconsin | 53211 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
| Aurora Sheboygan Memorial Medical Center | Sheboygan | Wisconsin | 53081 | — |
| Aurora Medical Center in Summit | Summit | Wisconsin | 53066 | — |
| Aurora Medical Center in Two Rivers | Two Rivers | Wisconsin | 54241 | — |
| Waukesha Memorial Hospital | Waukesha | Wisconsin | 53188 | — |
| Aspirus Wausau Hospital | Wausau | Wisconsin | 54401 | — |
| Aurora Health Care Metro, Inc. | Wauwatosa | Wisconsin | 53226 | — |
| UW Cancer Center-Riverview | Wisconsin Rapids | Wisconsin | 54494 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01281917, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 13, 2019 · Synced Oct 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01281917 live on ClinicalTrials.gov.